07:00 , Apr 3, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

This week in techniques Approach Summary Licensing status Publication and contact information Disease models Mouse model of dominant Ullrich congenital muscular dystrophy (UCMD) A mouse model of dominant UCMD with deletion of collagen type VI...
07:00 , Apr 25, 2013 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Mouse model for collagen type VI a3 (COL6A3)-related muscular dystrophies A mouse model for COL6A3-related muscular dystrophies could help identify new treatments. In mice, a...
07:00 , Oct 18, 2012 |  BC Innovations  |  Cover Story

Taking the fat out of cancer

Researchers from The University of Texas Southwestern Medical Center have shown that an antibody targeting endotrophin , a fat cell-derived extracellular protein, reduced growth of breast tumors in mice. 1 The team will next study...
07:00 , Oct 18, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Endotrophin Mouse studies suggest antagonizing endotrophin could help treat breast cancer. Endotrophin is a cleaved protein derived from collagen type VI a3 (COL6A3)....